IPAC2014 - List of Authors (Benedikt, M.)

Paper	Title	Page
MOXAA01	Challenges for Highest Energy Circular Colliders	1
	F. Zimmermann, M. Benedikt, D. Schulte, J. Wenninger CERN, Geneva, Switzerland
	A new tunnel of 80-100 km circumference could host a 100 TeV centre-of-mass energy-frontier proton collider (FCC-hh/VHE-LHC), with a circular lepton collider (FCC-ee/TLEP) as potential intermediate step, and a lepton-hadron collider (FCC-he) as additional option. FCC-ee, operating at four different energies for precision physics of the Z, W, and Higgs boson and the top quark, represents a significant push in terms of technology and design parameters. Pertinent R&D efforts include the RF system, top-up injection scheme, optics design for arcs and final focus, effects of beamstrahlung, beam polarization, energy calibration, and power consumption. FCC-hh faces other challenges, such as high-field magnet design, machine protection and effective handling of large synchrotron radiation power in a superconducting machine. All these issues are being addressed by a global FCC collaboration. A parallel design study in China prepares for a similar, but smaller collider, called CepC/SppC.
	Slides MOXAA01 [27.493 MB]
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2014-MOXAA01
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

WEPRO081	Status of MedAustron – The Austrian Ion Therapy and Research Centre	2146
	F. Osmić, A. Koschik, P. Urschütz EBG MedAustron, Wr. Neustadt, Austria M. Benedikt CERN, Geneva, Switzerland
	MedAustron is the Austrian centre for hadron therapy and non-clinical research. The accelerator design is based on the PIMMS study * and features proton beams of up to 800 MeV and carbon ion beams of up to 400 MeV/n. The accelerator is currently being installed and the beam commissioning has started early 2013. The injector comprising three ECR sources, an RFQ and an IH-mode structure has already been qualified; the synchrotron commissioning shall start in March 2014. Certification of the therapy accelerator following the European Medical Device Directive (MDD) is well under way with strong partners from industry involved in the process. The status of the overall facility including an overview of the recent commissioning results will be presented in this paper. * P. J. Bryant et al., “Proton-Ion Medical Machine Study (PIMMS), 2,” Aug 2000.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2014-WEPRO081
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Page

Challenges for Highest Energy Circular Colliders

1

F. Zimmermann, M. Benedikt, D. Schulte, J. Wenninger
CERN, Geneva, Switzerland

A new tunnel of 80-100 km circumference could host a 100 TeV centre-of-mass energy-frontier proton collider (FCC-hh/VHE-LHC), with a circular lepton collider (FCC-ee/TLEP) as potential intermediate step, and a lepton-hadron collider (FCC-he) as additional option. FCC-ee, operating at four different energies for precision physics of the Z, W, and Higgs boson and the top quark, represents a significant push in terms of technology and design parameters. Pertinent R&D efforts include the RF system, top-up injection scheme, optics design for arcs and final focus, effects of beamstrahlung, beam polarization, energy calibration, and power consumption. FCC-hh faces other challenges, such as high-field magnet design, machine protection and effective handling of large synchrotron radiation power in a superconducting machine. All these issues are being addressed by a global FCC collaboration. A parallel design study in China prepares for a similar, but smaller collider, called CepC/SppC.

Slides MOXAA01 [27.493 MB]

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2014-MOXAA01

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

WEPRO081

Status of MedAustron – The Austrian Ion Therapy and Research Centre

2146

F. Osmić, A. Koschik, P. Urschütz
EBG MedAustron, Wr. Neustadt, Austria
M. Benedikt
CERN, Geneva, Switzerland

MedAustron is the Austrian centre for hadron therapy and non-clinical research. The accelerator design is based on the PIMMS study * and features proton beams of up to 800 MeV and carbon ion beams of up to 400 MeV/n. The accelerator is currently being installed and the beam commissioning has started early 2013. The injector comprising three ECR sources, an RFQ and an IH-mode structure has already been qualified; the synchrotron commissioning shall start in March 2014. Certification of the therapy accelerator following the European Medical Device Directive (MDD) is well under way with strong partners from industry involved in the process. The status of the overall facility including an overview of the recent commissioning results will be presented in this paper.
* P. J. Bryant et al., “Proton-Ion Medical Machine Study (PIMMS), 2,” Aug 2000.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2014-WEPRO081

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)